Product

Nucleos(t)ide therapy

2 clinical trials

1 indication

Indication

Clinical trial

Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)

Status: Completed, Estimated PCD: 2022-03-18

Clinical trial

B-Fine: An Open Label, Single Arm Study to Mechanistically Interrogate the Therapeutic Effect of GSK3228836 in Patients With Chronic Hepatitis B Via Intrahepatic Immunophenotyping

Status: Active (not recruiting), Estimated PCD: 2023-12-14